Intervention of Ayurvedic Medicine (Arogya Kashayam) in Covid-19 positive cases (Asymptomatic and Mild Symptomatic)

Evaluation of efficacy of Arogya Kashayam in Asymptomatic and Mild Symptomatic Positive Cases of Covid-19 -A Randomized Control Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026221

Enrollment

100

Registered

2020-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Arogya Kashayam-20: Dose : 100 ml Frequency: Twice a day (morning and evening) Route: Oral. Duration: 10 days. Control Intervention1: Hydroxychloroquine (HCQ): Dose: First day - 800 mg

Eligibility

Inclusion criteria

Inclusion criteria: Asymptomatic and Mild cases of Covid-19 Aged between 16-60 years without any discrimination of gender, caste and religion Participants able to give Informed consent and follow the instructions

Exclusion criteria

Exclusion criteria: Severely symptomatic cases of Covid-19 (SaO2 Participants with Acute Respiratory Distress Syndrome (ARDS) Life expectancy less than 1 year due to other co-morbid conditions

Design outcomes

Primary

Measure	Time frame
Check the progression of the diseaseTimepoint: Base line, 3 days, 7 days	—

Secondary

Measure	Time frame
Conversion from mild symptomatic to asymptomatic casesTimepoint: Base line, 3 days, 7 days, 10 days	—

Countries

India

Contacts

Public ContactProf Umesh Shukla

Pt Khushilal Sharma Government Ayurveda College and Institute Bhopal

umeshayurvedabhopal@gmail.com9425373046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026